Rein Therapeutics Inc.
RNTX
$1.27
$0.1412.39%
NASDAQ
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Net Income | 23.71% | 22.66% | -458.40% | -220.03% | -400.39% |
Total Depreciation and Amortization | -75.00% | -- | -100.00% | -100.00% | -66.67% |
Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
Total Other Non-Cash Items | -21.47% | 76.00% | 8,188.62% | 173.12% | 31.45% |
Change in Net Operating Assets | -34.08% | -157.44% | 72.86% | 13,918.18% | 114.03% |
Cash from Operations | 23.50% | -17.15% | 53.69% | -132.87% | -169.22% |
Capital Expenditure | -- | -- | -- | -- | -- |
Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
Cash Acquisitions | -- | -- | -- | -- | -- |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | -- | -- | -- | -- | -- |
Cash from Investing | -- | -- | -- | -- | -- |
Total Debt Issued | -- | -- | -- | -- | -- |
Total Debt Repaid | -- | -- | -- | -- | -- |
Issuance of Common Stock | -88.70% | -- | -- | -- | -- |
Repurchase of Common Stock | -- | -- | -- | -- | -- |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -- | -- | -- | -- | -- |
Other Financing Activities | -52.04% | -- | -- | -- | -- |
Cash from Financing | -74.20% | -- | -99.99% | -- | -- |
Foreign Exchange rate Adjustments | -- | -- | 98.41% | -- | -- |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | -117.28% | -3.15% | -191.76% | -288.43% | 83.41% |